Background: Fractional absorption of zinc (Zn) has been measured using dual isotopes of Zn given simultaneously. An oral test dose and an intravenous (i.v.) reference dose are administered, followed by the measurement of the double isotopic enrichment (E) in urine 48 h after administration. We postulated that an estimate of the %E in urine for a given i.v. dose of Zn may be used to eliminate the need for venipuncture and the second Zn isotope. Objectives: To determine a constant (k) for the Zn enrichment of urine after i.v. administration of a dose of labeled Zn in Zn-replete subjects. To use 'k' to calculate fractional absorption of Zn, and to compare these values to values obtained using the standard dual isotope method. Design: Single-arm cohort. Setting: The Hospital for Sick Children, Toronto, Canada. Subjects: Twenty-three healthy adults were recruited from the Metropolitan Toronto area. Seventeen subjects completed the study. Interventions: A 2.29 mg i.v. dose of 67 Zn followed immediately by a 2.50 mg oral dose of 70 Zn. Results: Population mean percentage enrichment (%E) of 67 Zn in urine was 1.43 (95% CI 1.26, 1.60). The ratio of the i.v. dose to mean %E in urine (k) was estimated to be 1.60 mg (95% CI 1.43, 1.82). There was no difference in the mean fractional absorption of Zn calculated using the single compared to the dual isotope method: 12.58% (95% CI 2.22, 22.94) vs 12.68% (95% CI 4.52, 20.85), respectively (P ¼ 0.89). The correlation coefficient between the two methods was 0.81 (P < 0.0001).
Introduction
Zinc (Zn) isotopes have been used to study its absorption (Abrams, 1999) . Traditionally, absorption has been measured by calculating the difference between the mass of an isotopic dose administered orally and the mass of the subsequent tracer excreted in the feces (Wastney & Henkin, 1989) . This 'mass balance' method involves long and tedious fecal collection periods. Studies in adults (Friel et al, 1992; Lowe et al, 1997 Lowe et al, , 2000 and premature infants (Friel et al, 1996) used a dual-isotope method to estimate Zn absorption, while avoiding the need for prolonged fecal collection. In these studies, the Zn isotope ratio after ingestion of an oral dose of a Zn isotope was compared to a similar ratio after simultaneous intravenous (i.v.) infusion of a different Zn isotope. The ratios of isotopic enrichment were subsequently measured in a single urine sample. However, none of these studies determined whether there was a constant Zn isotope ratio in urine and plasma collected at similar times. Although the dual isotope method has some advantages over traditional balance studies, it is still invasive (requiring an i.v. infusion) and necessitates the purchase of two different isotopes. A single isotope method would be simpler and less expensive.
The dual isotope method was first established as a method for the determination of calcium absorption (Yergey et al, 1990) and modified by Friel et al for Zn. In both cases, the relative fraction of the oral to the intravenous tracer dose in a 24 h urine sample is determined and represents the fraction of the oral tracer dose that was absorbed (Abrams, 1999) . In stable isotope studies of iron absorption, a single-tracer technique is generally used. It is assumed that erythrocyte incorporation of 'absorbed' iron is similar among subjects. Incorporation is estimated to be 80% in non-anemic adult subjects (Janghorbani et al, 1986 ). This assumption is made to avoid having to give an i.v. dose of labeled iron each time iron absorption is determined.
Under normal circumstances, Zn homeostasis in the body appears to be maintained primarily by alterations in fractional Zn absorption and by changes in fecal excretion of endogenous Zn (Babcock et al, 1982) . Despite the observation that only small amounts of Zn are excreted in the urine (Zlotkin & Casselman, 1990) , it is assumed that urinary Zn has similar isotopic composition to plasma (Hillman et al, 1988) . Therefore, isotopic enrichment of urinary Zn should be proportional to plasma in a dosedependent manner after the i.v. administration of isotopes of Zn (Friel et al, 1992) . However, it has not been established whether the Zn isotope ratio after an i.v. dose of labeled Zn is similar among subjects. If so, we can estimate the urinary enrichment expected from a reference dose and avoid having to give the i.v. dose of labeled Zn. Thus the objective of the current study was to determine a constant (k) for the Zn enrichment of urine after i.v. administration of a similar dose of labeled Zn in Zn-replete subjects. This constant would then be used to calculate fractional absorption of Zn and compared to values obtained using the standard dual isotope method.
Subjects and methods

Subjects
Twenty-three healthy adults (no recent episodes of gastroenteritis, no chronic gastrointestinal disorders, afebrile), with normal Zn status were recruited from the Metropolitan Toronto area and gave written informed consent.
Preparation and administration of isotopes
Trace element-free sulfuric acid, sodium hydroxide (BDH Inc., Toronto, Canada) and high-purity distilled deionized water filtered through a 0.22 mm Millipore filtration system (Millipore, Bedford, MA) were used throughout the preparation of the i.v. and oral doses of Zn isotopes. All laboratory work was done in a clean laboratory under a laminar flow hood. Acid-washed glassware and plastics were used throughout. Zn). The pH of both solutions was adjusted to 4.0. The i.v. solution was passed through a 0.22 mm filter and stored in glass vials until time of injection. One vial was used for sterility testing and pyrogen testing with the Limulus Amebocyte Lysate Test Kit (Whittaker Bio-products, Walkersville, MD). The oral solution was aliquoted into 1.0 ml oral syringes and refrigerated until use. Both i.v. and oral solutions were assayed for total Zn concentration by atomic absorption spectrophotometry (Hitachi Ltd, Mountain View, CA). The i.v. and oral solutions had a final total Zn concentration of 0.245 and 3.00 mg=ml, respectively.
Procedure
Baseline urine (20 ml) and blood (5 ml) samples were taken before administration of the isotopes. Blood samples were immediately placed on ice after collection and the serum separated within half an hour in the laboratory and assayed for serum Zn concentration using ICP-OES (Optical Emission Spectrometer). An oral dose of 2.50 mg 70 Zn and an i.v. dose of 2.29 mg of a second isotope ( 67 Zn) were used in this study. These doses were adequate to achieve urinary Zn enrichment such that fractional absorption of Zn could be accurately determined (Friel et al, 1992) . Subjects were given the i.v. dose as a 5 min infusion using a butterfly syringe in an antecubital vein. The syringe was then flushed with 5 ml of sterile saline. Immediately afterwards, the oral dose was prepared by dispensing the contents of a premeasured oral syringe containing the isotope solution onto a spoonful of dried, rice-based infant cereal (Gerber Products Company, Fremont, MI). Rice-based cereal was used for two reasons: we wanted to examine the results in a typical Zn-fortified food containing phytic acid and because the nutrient content was known for each pre-packaged serving. The subjects were told to ingest the contents of the dosed spoon of cereal and then ingest the remaining 15 g of the cereal, using the same spoon. This ensured that the entire dose was taken. After the baseline urine collection, a single spot urine sample was collected approximately 48 h (AE 45 min) after administration of the doses. The study was approved by the Research Ethics Board at the Hospital for Sick Children, Toronto. Zn, were determined using a Perkin Elmer Series Elan 6000 inductively coupled mass spectrometer (ICP-MS). The instrument was optimized daily and operated as recommended by the manufacturer. A Perkin Elmer FIAS 400 was used as the flow injector and controlled by the Elan 6000 software. The FIAS 400 was connected directly to the ELAN 6000 nebulizer by Teflon tubing. A peristaltic pump was used to remove waste from the nebulizer. Toyopearl AF-Chelated-650 M resin with a particle diameter of 65 mm was packed into a Perkin-Elmer column. The column was connected to the FIAS 400 by Teflon tubing.
Determination of Zn isotope ratios in urine samples
Urine samples were buffered on-line to pH 8.5 and passed through the analytical column. The Zn was collected in the analytical column and the matrix components of urine passed through the column. Rejection of the matrix components of urine is imperative to reduce the interference from polyatomic ions to minimize signal suppression caused by ion -ion interactions or space charge effects on the interface region.
Following sample leaching, the column was washed with deionized water to remove the matrix residue and the Zn was eluted onto the plasma with 1 M HNO 3 . The samples were pre-concentrated for Zn to 50 mg=ml, 100 times the detection limit for ICP-MS.
The obtained isotope ratios were corrected for mass discrimination. Accuracy of the isotope ratio measurements was verified by analysis of a Zn nitrate standard (VWR Scientific). Zn, respectively.
Fractional Zn absorption
Fractional absorption of Zn was determined via the 'dual isotope' methodology outlined by Friel et al, (1992 Friel et al, ( , 1996 using the following equation:
Fractional absorption Fractional absorption ¼ k ðmgÞ Â ð%E of oral dose in urine =oral dose ðmgÞÞ ð4Þ
Sample size detectable difference The sample size calculation was based on a paired t-test analysis assuming an acceptable difference between the two methods to be equivalent to the standard deviation of fractional absorption, previously observed to be 12% (Friel et al, 1992 (Friel et al, , 1996 . Lacking any better estimate, we conservatively assumed the standard deviation of differences between the two methods to be 12% as well. Based on an a ¼ 0.05 and a b ¼ 0.90, the calculated sample size was 22 to detect a significant difference between the single and dual isotope methods. The actual observed standard deviation of differences was 3.9% and the sample size was 17. Based on these numbers, with an a ¼ 0.05, the actual power to detect a difference of 12% was 0.97. In fact, if we wanted the statistical power to be 0.90 with an n ¼ 17, we could detect a difference between methods as small as 3.2%.
Statistical analysis
Differences between the two methods of determining fractional absorption were assessed by paired t-test. The correlation coefficient between the two methods was also calculated. Other factors that may have affected urinary enrichment such as gender, weight or serum Zn were assessed by analysis of variance. All statistical analyses were performed using SAS software, version 7 (SAS Institute, Cary, NC, USA). P-values < 0.05 were considered significant.
Measurement agreement between each of the estimates of fractional absorption was determined according to the method of Bland and Altman (1986 , 1995 , 1999 . The 'limits of agreement' between two methods is defined as the differences between the means of the two methods plus or minus twice the standard deviation of the differences. In simple terms, the 'limits of agreement' describe the range by which one method over-or underestimates another. If this over-or underestimation is clinically significant, the methods do not agree and cannot be used interchangeably.
'Limits of agreement' ¼ ðmean 1 À mean 2 Þ AE 2ðs:d: of differencesÞ
Results
Subjects
Twenty-three subjects were initially recruited. Six (four female, two male) were eliminated from the analysis since they did not provide a urine sample at 48 h. A greater number of females (n ¼ 12) completed the study compared to males (n ¼ 5). Characteristics of the 17 subjects studied are summarized in Table 1 .
Fractional absorption of Zn calculated by the dual isotope method
The mean fractional absorption of Zn using the dual isotope method was 12.68% (95% CI 4.52, 20.85).
Calculation of constant (k)
Based on an i.v. dose of 2.29 mg of 67 Zn, the mean percentage enrichment of 67 Zn in urine was 1.43 (95% CI 1.26, 1.60). Thus, the population mean for the ratio of the i.v. dose to %E in urine (k) was estimated to be 1.60 mg (95% CI 1.43, 1.82). Urinary enrichment of 67 Zn was not affected by gender, weight or serum Zn concentration.
Fractional absorption of Zn calculated by the single isotope method
The mean fractional absorption of Zn using k ¼ 1.60 mg (the single isotope method) was 12.58% (95% CI 2.22, 22.94).
Comparison of dual vs single isotope method for calculating fractional absorption Defined 'limits of agreement' were calculated (Bland & Altman, 1986) . The single isotope method to calculate Zn absorption yielded values 4.78 percentage points below or 4.98 above those calculated using the dual isotope method for a given individual (Figure 1 ). There was no difference in the mean fractional absorption of Zn calculated using the single compared to the dual isotope method: 12.58% (95% CI 2.22, 22.94) vs 12.68 (95% CI 4.52, 20.85) respectively (P ¼ 0.89). The correlation coefficient between the two methods was 0.81 (P < 0.0001) (Figure 2) .
Discussion
This study demonstrated that estimates of fractional Zn absorption with a single isotope yields similar results to the dual isotope method in healthy adults with normal Zn status. A constant was derived to estimate fractional absorption with the single isotope.
We chose to measure %E in urine 48 h after dosing, because rapid exchange between Zn pools occurs within 48 h (Miller et al, 1994) . Furthermore, slopes of isotopic disappearance curves, derived from urine isotope ratios after administration of oral and i.v. doses, decline in a proportional manner beyond 40 h after administration of the isotopes (Friel et al, 1992 (Friel et al, , 1996 . We hypothesized that, in healthy adults, the normally tight control over plasma Zn concentrations (King, 1990) reflected in urinary isotopic ratios would be reasonably consistent among subjects. This was indeed the case. Percentage enrichment of 67 Zn in urine was not affected by age, weight (which is proportional to plasma volume), gender or Zn status in this study. This is consistent with previous studies that suggested that age or body size did not influence renal handling of Zn (Friel et al, 1992 (Friel et al, , 1996 .
We were able to replace the individual i.v. enrichment ratios with a constant to calculate fractional absorption of Zn. This is reflected in the significant and strong correlation between the single and dual isotope methods. The use of 'limits of agreement' to decide whether one method can be used in place of another usually depends on an estimate of the clinical significance of the Zinc absorption using single isotope GS Yeung et al differences between the methods. Since fractional absorption of Zn is not in itself a clinically important diagnostic measure, whether or not the single isotope method can be used in place of the dual isotope method depends on its application. Estimates of Zn absorption are often used to determine responses in populations, rather than individuals. If the goal of the method is to ascertain the exact fractional absorption of Zn in an individual, the single isotope may not be sensitive enough to replace the dual isotope method. On the other hand, for populations of individuals, where the accuracy of fractional absorption for each individual is less important than the overall mean of the population, the single isotope method may be used in place of the dual isotope method. In the current study, the mean values for the entire sample were virtually identical using the two methods. Certainly the single isotope method is considerably simpler to use. It involves the ingestion of a single oral isotope and a single timed-urine collection, compared to the dual isotope method which involves the ingestion of the oral isotope and the i.v. infusion of a second pyrogen-free sterile isotope combined with a timed urine collection. Avoiding the need for venipuncture and the reduction in cost by using only a single isotope would make Zn absorption studies more feasible. However, more research is required to determine the universal applicability of the constant estimated in the current study (k ¼ 1.60 mg; 95% CI 1.43, 1.82). We have demonstrated in a group of Znreplete healthy adult subjects that the use of the constant (k) gives acceptable results. However, similar studies, in varied populations (for example, children or Zn-depleted subjects) are required to directly demonstrate that k as a replacement for the i.v. dose can be used. Such studies are currently underway. Although the current, as well as other studies (Friel et al, 1992 (Friel et al, , 1996 , suggest that age and body size (hence plasma volume) do not affect serum Zn homeostasis, the total number of subjects included in this study was not sufficient to definitively make this conclusion.
Despite these limitations, the use of a single isotope and single timed-urine sample for determining Zn absorption has widespread potential application. The method is inexpensive, non-invasive and simple to execute. It may prove useful in providing quantitative information on the bioavailability of Zn over a range of dietary and clinical circumstances (Hambidge et al, 1998) , particularly when different interventions are compared within the same population. Such applications may include determining the relative differences in bioavailability of different Zn compounds used in supplements or in the fortification of foods, determining the relative effects of phytates and minerals such as iron and calcium on Zn absorption, and assessing the efficacy of intervention strategies designed to increase Zn absorption in populations.
